mafosfamide has been researched along with Leukemia, Biphenotypic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chelstrom, LM; Gunther, R; Jansen, B; Jaszcz, WB; Kersey, JH; Nguyen, DP; Tuel-Ahlgren, L; Uckun, FM | 1 |
1 other study(ies) available for mafosfamide and Leukemia, Biphenotypic, Acute
| Article | Year |
|---|---|
Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.
Topics: Acute Disease; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents, Phytogenic; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cyclophosphamide; Female; Humans; Immunotoxins; Leukemia, Biphenotypic, Acute; Leukemic Infiltration; Male; Mice; Mice, SCID; Molecular Sequence Data; N-Glycosyl Hydrolases; Oligonucleotide Probes; Plant Proteins; Polymerase Chain Reaction; Ribosome Inactivating Proteins, Type 1; Specific Pathogen-Free Organisms; Translocation, Genetic | 1993 |